On-Pump Coronary Artery Bypass Graft: The State of the Art

Giovanni Cuminetti1, Ivano Bonadei1, Enrico Vizzardi1

  • 1Cardiology Unit, Department of Experimental and Applied Medicine, University of Brescia, Brescia, Italy.

Insights

Coronary artery bypass grafting (CABG) is a standard treatment for coronary artery disease (CAD), showing better outcomes than percutaneous coronary intervention (PCI), especially for diabetic patients. Further research is needed to confirm these benefits.

Area of Science:

  • Cardiovascular Surgery
  • Interventional Cardiology
  • Clinical Outcomes Research

Background:

  • Coronary artery bypass grafting (CABG) is the established standard of care for patients with coronary artery disease (CAD).
  • Ongoing debates exist regarding optimal surgical strategies, including graft choices (e.g., mammary artery vs. radial artery vs. saphenous vein) and surgical techniques (e.g., endoscopic vs. open harvesting, on-pump vs. off-pump).
  • Special considerations are necessary for managing diabetic patients with CAD undergoing CABG.

Purpose of the Study:

  • To review current indications for CABG in patients with coronary artery disease (CAD).
  • To report on contemporary practice patterns in CABG procedures.
  • To summarize the outcomes associated with CABG, comparing it with alternative treatments.

Main Methods:

  • A systematic search of randomized controlled trials comparing CABG to other therapeutic strategies for CAD was conducted.
  • Databases searched included MEDLINE, EMBASE, and Cochrane.
  • Proceedings of international meetings were also reviewed.

Main Results:

  • Large-scale studies (SYNTAX, BEST, PRECOMBAT, ASCERT) demonstrate superior outcomes for CABG compared to percutaneous coronary intervention (PCI), with lower rates of operative mortality and major morbidity.
  • Long-term follow-up (10 years) of the ARTS II trial indicated no significant difference between single and bilateral internal mammary artery grafts.
  • Trials such as BARI 2D, MASS II, CARDia, and FREEDOM identified CABG as the preferred revascularization strategy for diabetic patients with CAD.

Conclusions:

  • Coronary artery bypass grafting (CABG) remains a highly prevalent major surgical procedure with proven benefits for symptom relief and prognosis in patients with coronary artery disease (CAD).
  • While evidence supports the efficacy of CABG, continued research and long-term follow-up studies are essential to further validate these findings.
  • Optimal management strategies, particularly for complex patient subsets like diabetics, continue to evolve.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.0K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
415
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
246
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
359
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
658
ATP Driven Pumps III: V-type Pumps01:30

ATP Driven Pumps III: V-type Pumps

V-type pumps are ATP-driven pumps found in the vacuolar membranes of plants, yeast, endosomal and lysosomal membranes of animal cells, plasma membranes of a few specialized eukaryotic cells, and some prokaryotes. They are also known as the V1Vo-ATPase, that couple ATP hydrolysis to transport protons against a concentration gradient.
The peripheral or cytosolic V1 domain with eight subunits is involved in ATP hydrolysis. The integral or transmembrane V0 domain containing at least five subunits...
4.8K